Bridgefront Capital’s Ocugen OCGN Stock Holding History

Bridgefront Capital’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-16,822	Closed	-$135K	–	581
2021 Q2	$135K	Buy	+16,822	New	+$142K	0.05%	540

Other funds holding OCGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bridgefront Capital's OCGN Position: Q3 2021 in Review

Bridgefront Capital sold out of Ocugen (OCGN) in Q3 2021, closing a stake of 16,822 shares — an estimated $135K sold.

Bridgefront Capital first reported a position in OCGN in Q2 2021 and held it in 1 quarter. The position peaked at $135K in Q2 2021. 116 funds tracked by Wall St. Rank hold OCGN as of Q3 2021.

Bridgefront Capital reported no remaining Ocugen position as of Q3 2021 after selling out during the quarter.
Bridgefront Capital sold 16,822 Ocugen shares in Q3 2021, an estimated $135K.
Bridgefront Capital first reported a position in Ocugen in Q2 2021 and held it in 1 quarter.
Bridgefront Capital's Ocugen position peaked at $135K in Q2 2021.
116 funds tracked by Wall St. Rank held Ocugen as of Q3 2021.

Based on Bridgefront Capital's 13F filing for Q3 2021, filed 12 Nov 2021.